Effects of umeclidinium/vilanterol on exercise endurance in COPD: a randomised study
This multicentre, randomised, double-blind, placebo-controlled, two-period crossover study assessed the effect of umeclidinium/vilanterol (UMEC/VI) on exercise capacity in patients with chronic obstructive pulmonary disease (COPD) using the endurance shuttle walk test (ESWT). Patients were randomise...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2018-01-01
|
| Series: | ERJ Open Research |
| Online Access: | http://openres.ersjournals.com/content/4/1/00073-2017.full |